Actinium Pharmaceuticals
ATNM
#10338
Rank
โ‚น4.63 B
Marketcap
โ‚น147.45
Share price
1.95%
Change (1 day)
24.98%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): โ‚น0.98 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚น35.09 Million. In 2025 the company made an earning of -โ‚น3.41 Billion, an increase over its 2024 earnings that were of -โ‚น3.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น0.98 B-128.88%
2025 -โ‚น3.41 Billion-13.95%
2024 -โ‚น3.96 Billion-18.87%
2023 -โ‚น4.88 Billion52.24%
2022 -โ‚น3.21 Billion36.61%
2021 -โ‚น2.35 Billion11.48%
2020 -โ‚น2.11 Billion1.46%
2019 -โ‚น2.08 Billion-7.37%
2018 -โ‚น2.24 Billion-11.46%
2017 -โ‚น2.53 Billion10.67%
2016 -โ‚น2.29 Billion15.7%
2015 -โ‚น1.98 Billion-14.86%
2014 -โ‚น2.32 Billion129.19%
2013 -โ‚น1.02 Billion-8.55%
2012 -โ‚น1.11 Billion
2010 โ‚น0.77 M-152.15%
2009 -โ‚น1.5 Million-39.8%
2008 -โ‚น2.49 Million120.29%
2007 -โ‚น1.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-โ‚น3.5 Billion-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น17.93 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.10 B 356.94%๐Ÿ‡บ๐Ÿ‡ธ USA